CSF3 and Decreased total neutrophil count: An open-label, randomized, phase II study had as the primary endpoint evaluation of the duration of grade 4 neutropenia after one cycle of toposide, methylprednisolone, cisplatin and cytarabine with the two different G-CSF strategies.